Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer



Status:Active, not recruiting
Conditions:Breast Cancer, Neurology
Therapuetic Areas:Neurology, Oncology
Healthy:No
Age Range:18 - 99
Updated:1/30/2019
Start Date:June 13, 2011
End Date:June 5, 2020

Use our guide to learn which trials are right for you!

A Phase 1b/2 Randomized Study of MEDI-573 in Combination With an Aromatase Inhibitor (AI) Versus AI Alone in Women With Metastatic Breast Cancer (MBC)

Study to evaluate the safety, tolerability, antitumor activity, and pharmacology of MEDI-573
in combination with an aromatase inhibitor (AI) in adult subjects with HR+, HER2-negative
MBC.

This is a Phase 1b/2, multicenter, open-label study to evaluate the safety, tolerability,
antitumor activity, and pharmacology of MEDI-573 in combination with an AI in adult subjects
with HR+, HER2-negative MBC. This study has 2 phases: a dose-evaluation phase (Phase 1b) and
a randomization phase (Phase 2).

Inclusion Criteria:

- Histologically-confirmed MBC not deemed amenable to curative surgery or curative
radiation therapy

- Tumors are positive for ER, PgR, or both

- Tumors must be negative for HER2 (by FISH, CISH or IHC)

- Female gender and age ≥ 18 years at time of study entry

- Postmenopausal

- Karnofsky Performance Status ≥ 70

- Life expectancy of ≥ 6 months

Exclusion Criteria:

- Subjects who received prior chemotherapy, hormonal therapy, immunotherapy or biologic
therapy for advanced or metastatic disease with the following exceptions:

- Prior adjuvant therapy with an AI and/or tamoxifen is allowed, provided treatment
ended at least 2 weeks prior to the first dose of MEDI-573

- Prior neoadjuvant and/or adjuvant chemotherapy for breast cancer is allowed

- Extensive symptomatic visceral disease including hepatic involvement and pulmonary
lymphangitic spread of tumor, or disease that is considered by the investigator to be
rapidly progressing or life threatening (eg, subjects who are intended for
chemotherapy)

- Active brain metastases with the exception of subject has been treated and are
asymptomatic and there has been no evidence of CNS progression for at least 4 weeks of
first dose of MEDI-573

- Evidence of ongoing spinal cord compression or leptomeningeal carcinomatosis

- Unresolved toxicities from prior therapy with the exception of alopecia that have not
resolved to ≤ Grade 1 at the time of starting study treatment

- Previous treatment with agents that target the IGF receptor

- History of allergy or reaction attributed to compounds of chemical or biologic
composition similar to those of MEDI-573 or AI

- History of another invasive malignancy within 5 years except for curatively resected
nonmelanoma skin cancer or carcinoma in situ of the cervix

- Poorly controlled diabetes mellitus
We found this trial at
32
sites
?
mi
from
Rockville, MD
Click here to add this to my saved trials
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Athens, GA
Click here to add this to my saved trials
?
mi
from
Augusta, GA
Click here to add this to my saved trials
?
mi
from
Bakersfield, CA
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Bethesda, MD
Click here to add this to my saved trials
?
mi
from
Canton, OH
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
?
mi
from
Frederick, MD
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Lake Success, NY
Click here to add this to my saved trials
?
mi
from
Lansing, MI
Click here to add this to my saved trials
?
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
?
mi
from
Lubbock, TX
Click here to add this to my saved trials
?
mi
from
Memphis, TN
Click here to add this to my saved trials
?
mi
from
Middletown, OH
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
Nassau,
Click here to add this to my saved trials
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Pleasant Hill, California 94522
?
mi
from
Pleasant Hill, CA
Click here to add this to my saved trials
?
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
?
mi
from
Richmond, VA
Click here to add this to my saved trials
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Saint Petersburg, Florida 33713
?
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
?
mi
from
Scarborough, ME
Click here to add this to my saved trials
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
?
mi
from
Stamford, CT
Click here to add this to my saved trials
?
mi
from
Toledo, OH
Click here to add this to my saved trials